Anna Durrans

2.1k citations
5 papers · 1.7k · 1 hit paper · h-index 5

Impact in

    • Cancer Genomics and Diagnostics
    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • Cancer, Hypoxia, and Metabolism
  • Oncology top 2%
    • Cancer Cells and Metastasis

Papers in

    • Cancer Genomics and Diagnostics 2
    • MicroRNA in disease regulation 2
    • Protease and Inhibitor Mechanisms 1
    • Cancer, Hypoxia, and Metabolism 1
    • Cancer Cells and Metastasis 3

Anna Durrans

5 papers receiving 1.7k citations

Anna Durrans's Hit Papers

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance 2015 · 1.5k citations
1.5k0+3+7Years since publication4008001.2k

Peers

Anna Durrans
Comparison fields: 5 of 81
  • Cancer Research 578
  • Oncology 920
  • Molecular Biology 934
  • Cell Biology 186
  • Immunology 164
Replace Kari R. Fischer with:
Kari R. Fischer United States
Sharrell Lee United States
Alvaro Avivar‐Valderas United States
Robert J. Norgard United States
Tina El Rayes United States
Hyejin Choi United States
Nikolina Radulovich Canada
Kimberly A. Hartwell United States
Remedios Castelló-Cros United States
Vanesa L. Silvestri Italy
Anna Durrans relative to Kari R. Fischer United States Kari R. Fischer's profile →
Citations per field
00.5×1.5×
Kari R. Fischer · 1×
Citations per year

Countries citing papers authored by Anna Durrans

Since Specialization
Citations

This map shows the geographic impact of Anna Durrans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Durrans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Durrans more than expected).

Fields of papers citing papers by Anna Durrans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Durrans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Durrans. The network helps show where Anna Durrans may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Durrans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Durrans Line = papers co-authored together Anna Durrans links everyone, so they are left out of the graph.

All Works

5 of 5 papers shown
#Work
1
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Hit paper breakdown →
20151472
2 2015126
3 201650
4 201026
5 201517

About Anna Durrans

Anna Durrans is a scholar working on Cancer Research, Oncology, Biotechnology, Cell Biology and Molecular Biology, having authored 5 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (3 papers), Cancer Genomics and Diagnostics (2 papers), MicroRNA in disease regulation (2 papers), Zebrafish Biomedical Research Applications (1 paper), Cancer Research and Treatments (1 paper), Protease and Inhibitor Mechanisms (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Signaling Pathways in Disease (1 paper). The work is most often cited by research in Cancer Research (578 citations), Oncology (920 citations), Molecular Biology (934 citations), Cell Biology (186 citations) and Immunology (164 citations). Anna Durrans has collaborated with scholars based in United States and South Korea. Frequent co-authors include Dingcheng Gao, Vivek Mittal, N.K. Altorki, Hyejin Choi, Seongho Ryu, Jianting Sheng, Stephen T.C. Wong, Fuhai Li, Tina El Rayes and Kari R. Fischer. Their work appears in journals such as PLoS ONE, Nature, Cell Reports, Neoplasia and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact